CPHI — China Pharma Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $4.48m
- $6.44m
- $7.01m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.07 | 0.958 | 4.86 | 2.03 | 1.42 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.728 | 0.586 | 0.836 | 0.909 | 0.73 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.58 | 5.32 | 9.09 | 5.96 | 6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16.5 | 15.6 | 13.4 | 10 | 7.22 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 22.2 | 21.1 | 22.6 | 17.8 | 16.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10 | 11.4 | 10.5 | 12.7 | 6.82 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 13 | 13.1 | 16.6 | 13.5 | 9.01 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 9.24 | 8 | 6.02 | 4.29 | 7.45 |
Total Liabilities & Shareholders' Equity | 22.2 | 21.1 | 22.6 | 17.8 | 16.5 |
Total Common Shares Outstanding |